Why Arcadium Lithium, Core Lithium, Fortescue, and Mesoblast shares are pushing higher

These ASX shares are having a good session on Thursday. But why?

| More on:
A young woman wearing overalls and a yellow t-shirt kicks one leg in the air showing excitement over the latest ASX 200 shares to hit 52-week highs

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is continuing its positive run. At the time of writing, the benchmark index is up 0.45% to 7,595.4 points.

Four ASX shares that are rising more than most today are listed below. Here's why they are climbing:

Arcadium Lithium (ASX: LTM)

The Arcadium Lithium share price is up 1.5% to $10.89. This afternoon the lithium miner revealed that it has received COMEX approval for the development of the James Bay Lithium in Quebec, Canada. Management notes that this means it is "positioned to execute this tier 1 project with detailed engineering well advanced prior to the commencement of construction."

Core Lithium Ltd (ASX: CXO)

The Core Lithium share price is up 7% to 25.75 cents. This may have been driven by bargain hunters swooping in on the belief that the lithium miner's shares were oversold following a disappointing update. For example, even after today's gain, the Core Lithium share price is down 24% since this time last week.

Fortescue Ltd (ASX: FMG)

The Fortescue share price is up 2% to $29.14. Investors have been buying Fortescue and other iron ore miners today after the price of the steel-making ingredient rose again. The benchmark iron ore price has climbed to US$140 per tonne, which bodes well for Fortescue's profits in FY 2024. Its shares hit a new record high today.

Mesoblast Ltd (ASX: MSB)

The Mesoblast share price is up 3.5% to 30 cents. This morning, this biotechnology company revealed that a couple of insiders have been buying shares on-market. According to the release, Joseph Swedish picked up US$100k worth of shares and Philip Krause made a US$40k purchase. Both directors were buying its Wall Street-listed shares during last night's session.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Unsure man analysing data on laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a rough start to the trading week for investors.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Share Gainers

Why A2 Milk, Audinate, BlueScope, and Chalice Mining shares are rocketing today

These shares are starting the week with an almighty bang. But why?

Read more »

two men in hard hats and high visibility jackets look together at a laptop screen that one of the men in holding at a mine site.
Share Gainers

Guess which ASX 300 stock is surging 12% on a US government deal

The ASX 300 stock looks to be benefiting from the Donald Trump presidency.

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a spectacular end to the trading week for the ASX today.

Read more »

Three people jumping cheerfully in clear sunny weather.
Share Gainers

These 3 ASX 200 stocks are shooting the lights out this week. Own any?

These ASX 200 shares have soared 11% to almost 23% this week. But why?

Read more »

Two smiling work colleagues discuss an investment or business plan at their office.
Share Gainers

Why GQG, Imugene, Mirvac, and Temple & Webster shares are pushing higher

These shares are ending the week on a positive note. But why?

Read more »

Happy shareholders clap and smile as they listen to a company earnings report.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a momentous day for ASX shares, with the index hitting another record...

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

Up 135% in a year, why this ASX 200 healthcare stock is 'on track to become a truly great Australian success'

A leading fund manager expects more strong performance from this surging ASX 200 healthcare stock.

Read more »